Understanding the Potential of mRNA as Biomarker to Revolutionize Diagnosis of Colorectal Cancer.
Rina DasDinesh Kumar MehtaNidhi GuptaPublished in: Drug research (2024)
MicroRNA as potential biomarker for early diagnosis, differentiating various stages, interpreting the success of postoperative curative surgery and predicting early relapse of Colorectal cancer.In the realm of medical research, the quest to find effective biomarkers for various diseases has always been a top priority. Colorectal cancer (CRC), one of the leading causes of cancer-related deaths worldwide, is no exception. The emergence of microRNA (mRNA) as a potential biomarker for CRC has sparked immense interest among scientists and clinicians alike. mRNA, a molecule responsible for translating genetic information into functional proteins, presents a promising avenue for early detection and personalized treatment of this deadly disease. By analyzing the specific patterns and levels of mRNA expression in CRC cells, researchers have the ability to identify signatures that can aid in accurate diagnosis, predict patient prognosis, and even guide targeted therapies. This breakthrough in molecular biology not only enhances our understanding of CRC but also holds the potential to revolutionize the field of cancer diagnostics and treatment. In this article, we will delve deeper into the potential of mRNA as a biomarker for CRC, exploring its benefits and challenges in the field of cancer research.
Keyphrases
- papillary thyroid
- binding protein
- healthcare
- minimally invasive
- induced apoptosis
- computed tomography
- patients undergoing
- magnetic resonance
- palliative care
- magnetic resonance imaging
- gene expression
- coronary artery bypass
- cell cycle arrest
- health information
- climate change
- social media
- mass spectrometry
- signaling pathway